Topics

Companies Related to "A Trial to Evaluate the Combination Efficacy of Artificial Dermis and Growth Factor in Chronic Wounds Ulcer" [Most Relevant Company Matches] RSS

03:48 EST 25th January 2020 | BioPortfolio

Here are the most relevant search results for "A Trial to Evaluate the Combination Efficacy of Artificial Dermis and Growth Factor in Chronic Wounds Ulcer" found in our extensive corporate database of over 50,000 company records.

Showing "Trial Evaluate Combination Efficacy Artificial Dermis Growth Factor" Companies 1–25 of 3,200+

Relevant

BTI

BTI has been manufacturing growth factor (GF) and attachment factor (AF) products since 1981. Our extensive product line includes receptor-grade, aseptically packaged GFs and AFs. These are highly purified proteins that have been membrane filtered, aseptically filled and lyophilized. Most BTI GFs have been tested in cell culture, receptor binding studies and in immunoassays. Some GFs are availa...


Globe Laboratories

Globe Labs manufactures and sells high quality, low cost human therapeutic proteins, human growth hormones, enzymes, research laboratory cytokines, chemokines & their respective inhibitors/antagonists for research and veterinary use. We are also manufacturers of bulk quantities for other pharmaceutical companies worldwide. Globe Labs is proud to have the largest antagonist product list in the worl...

Aurinia Pharmaceuticals Inc.

Aurinia is a clinical stage pharmaceutical company focused on the global nephrology market. It is currently enrolling patients in its Phase 2b clinical trial to evaluate the efficacy of its drug, voclosporin, as a treatment for lupus nephritis (“LN”). LN is an inflammation of the kidneys, that if inadequately treated can lead to end-stage renal d...


Biomed Comm Incorporated

Biomed Comm TM (BMC) was founded in May 1996 to manufacture Dr.Brewitt's proprietary growth factor products known as Cell Signal Enhancers® (CSE®). The company's homeopathic growth factors represent a new class of medicines combining today's advanced biotechnologies, electro-magnetic field theory and basic homeopathic principles formed over two centuries ago. Biomed CommTM currently manufact...

IBT

ibt develops, manufactures and distributes reagents (monoclonal and polyclonal antibodies, proteins, peptides, antigens) for infectious disease research, transcription, growth factor and cytokine research and assay kits for the detection of growth factors, e.g. insulin-like growth factors (IGF´s) and insulin-like growth factor binding proteins (IGFBP´s).

SanBio Co., Ltd.

SanBio (TOKYO:4592) is a leading regenerative medical products company headquartered in Tokyo and Mountain View, California, with cell-based products in various stages of research, development and clinical trials. The company has completed enrollment for and is conducting a Phase 2b clinical trial for its proprietary regenerative medical product SB623 for ...

Polynoma, Inc.

Polynoma, Inc. is an oncology-focused biotechnology company based in San Diego, the United States of America. Polynoma’s lead product candidate is the therapeutic vaccine POL 103A for the treatment of melanoma. The Phase 3 trial of POL 103A was initiated based on two randomized, controlled Phase 2 trials that showed statistically significant efficacy ...

Minerva Biotechnologies

Minerva Biotechnologies is a pioneer in the field of stem cells and cancer stem cells. Minerva was first to discover that cancer cells hijack an otherwise normal stem cell growth mechanism, involving a growth factor receptor called MUC1* (pronounced muk 1 star). By studying human stem cells in parallel with human cancer cells, Minerva scientists figured ou...

Fit Factor Network, Inc.

Fit Factor Network, Inc. was founded by Hillsborough County physical education teacher, Scott Owen, for the purpose of improving the health of children and families. The company produces the Fit Factor Kids DVD - a 45 minute exercise DVD developed for and hosted by kids. The DVD is comprised of six workouts and three educational Fit Tip segments. For additional information, visit www.FitFactorKids...

Accredo Nova Factor

For more than 20 years, Accredo Nova Factor has provided nationwide distribution and pharmaceutical care management for the biopharmaceutical industry. Accredo Nova Factor currently has 15 product lines that are dispensed from its specialty pharmacy headquarters in Memphis, Tenn. The products are usually shipped overnight to the patients' homes, where patients are trained to reconstitute and self-...

NephRx Corporation

NephRx Corporation is a biotechnology company dedicated to the discovery and development of therapeutic products for the treatment of acute kidney failure and other renal disorders and diseases of the gastrointestinal tract, including mucositis, Crohn's disease and ulcerative colitis. Lead product NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical dev...

Sangamo BioSciences, Inc.

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has two Phase 1 clinical tri...

Genomic Discovery Tools, U.S.

TransFind is a tool for the identification of potential transcription factor complexes several genes in a genelist have in common. TransFind can be used for searching transcription factor binding sites results from MEME , GIBBS , & TESS visually. Transfind can also be used to create an oligonucleotide decoy for a transcription factor of interest and move forward in RNAi target selection. Recent us...

Evaluate Ltd.

Established in 1996, Evaluate Ltd. is the leader in high quality life science sector analysis. EvaluatePharma delivers exclusive consensus forecasts and trusted commercial insight into biotech and pharmaceutical performance. EvaluateMedTech sets a new standard in integrated analysis and consensus forecasts of the global medical device and diagnostic indust...

ERT

Based in Philadelphia, PA, eResearchTechnology, Inc. (www.ert.com) is a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries. The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. It is also a leading provider of centrali...

Evaluate, Ltd.

Evaluate is the trusted source for life science market intelligence and analysis with exclusive consensus forecasts to 2020. Evaluate supports life science and healthcare companies, financial institutions, consultancies and service providers in their strategic decision-making. Its services include EvaluatePharma, EvaluateClinicalTrials and EvaluateMedTe...

SynCardia Systems, Inc.

SynCardia Systems, Inc. is the Tucson-based manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artificial Heart. There have been more than 850 implants of the Total Artificial Heart, accounting for more than 190 patient years of life on the device.

A. F. Schuetzdeller Biochemicals

AFSBIO distributes growth fators and antibodies, with a special emphasis on Insulin-like Growth Factor (IGFs) and IGF Binding Proteins (IGFBPs). Products that have been develloped in house are biotinylated IGFs and western-ligand blotting kits for the detection of IGFBPs. In addition a range of reagents for research in infectious diseases and transcription are available. Custom assay development a...

Artificial Cell Technologies, Inc.

Artificial Cell Technologies, Inc. is an early-stage biomedical nanotechnology company founded in 2002 to commercialize applications of a new proprietary technology platform involving designed polypeptides. Our long term vision is to commercialize biotechnology applications for successively more sophisticated versions of an artificial bionanomachine: the artificial cell. ACT was founded to achie...

Protalex, Inc.

Protalex, Inc. is a clinical stage biopharmaceutical company that is developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex’s lead product PRTX-100, which is formulated with a highly-purified form of staphylococcal protein A, has completed a Phase 1b...

Tercica

Tercica, Inc., based in Brisbane, Calif., is a biopharmaceutical company committed to improving endocrine health. We are helping patients by partnering with the scientific and medical community to develop and commercialize therapeutics for growth and other endocrine disorders. In January 2006, less than four years after Tercica was founded, we commercially launched Increlex™ (mecasermin [rDNA ...

Q Factor

Q Factor radically improves user experiences over today’s increasingly congested wireless networks by streamlining the distribution of content. As the world becomes more unwired, users still expect their browsing or viewing experiences on any device, in any location, to be consistent, uninterrupted and high quality. For this to happen, a lot of complex ...

NitroMed

NitroMed, Inc. of Lexington, Massachusetts is a research-based emerging pharmaceutical company and the maker of BiDil, an orally administered medicine available in the United States for the treatment of heart failure in self-identified black patients. In this population, BiDil is indicated as an adjunct to current standard therapies such as ACE inhibitors and/or beta blockers. BiDil was approved b...

Forbius

Forbius is a clinical stage company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. Forbius’ medicines are designed to radically transform patients’ lives. We use our strength in biological understanding and diverse protein engineering technologies to design superior inhibitors of validated pathways. W...

ibt - immunological & biochemical testsystems GmbH

ibt - immunological and biochemical testsystems GmbH is a company dedicated to supply the scientific community with reagents and assays. Our reagents are recombinant proteins (viral and bacterial antigens, cytokines and chemokines, growth factors, hormones, transcription factors, tumor markers, enzymes and others) and polyclonal and monoclonal antibodies. Our main interest is in insulin-like grow...


More From BioPortfolio on "A Trial to Evaluate the Combination Efficacy of Artificial Dermis and Growth Factor in Chronic Wounds Ulcer"

Quick Search

Corporate Database Quicklinks